We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel TIMP/IMP technology and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.


John. J. Puisis

Co-Founder, President and Chief Executive Officer

Catherine “Kitty” Mackey, PHD

Chairman of the Board

Jim Herrmann

Co-founder, Chief Operating Officer

Amy Morris

Vice President of Clinical Development and Regulatory Affairs

Adam Elhofy, PHD

Vice President of Product Research and Collaborations

Michael Boyne, PHD

Vice President of Product Development and Analytics

Frank Fokta, PHD

Director of Quality

Jill Heady

Vice President of Finance and Administration

Olga Jasinsky

Director of Operations

Joseph Podojil, PHD

Senior Scientist

Tim Toby, PHD

Senior Development Scientist

Sam Magnuson

Business Analyst


Roy First, MD

Medical Advisor

Kari Nadeau, MD, PHD

Stanford University

Ciaran P. Kelly, MD

Harvard Medical School

Stephen D. Miller, PHD

Northwestern University

Nick King, MD, PHD

University of Sydney Australia

Lonnie D. Shea, PHD

University of Michigan